ALPHA-MSH RECEPTOR AUTORADIOGRAPHY ON MOUSE AND HUMAN-MELANOMA TISSUE-SECTIONS AND BIOPSIES

Citation
C. Bagutti et al., ALPHA-MSH RECEPTOR AUTORADIOGRAPHY ON MOUSE AND HUMAN-MELANOMA TISSUE-SECTIONS AND BIOPSIES, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 427-442
Citations number
35
Categorie Soggetti
Cell Biology",Biology
ISSN journal
10799893
Volume
15
Issue
1-4
Year of publication
1995
Pages
427 - 442
Database
ISI
SICI code
1079-9893(1995)15:1-4<427:ARAOMA>2.0.ZU;2-V
Abstract
MSH receptors and their binding characteristics of [I-125]-labelled de rivatives of alpha-MSH have been studied extensively on various mouse and human melanoma cell lines in culture. The aim of this study was to determine the binding characteristics of alpha-MSH radioligands to MS H receptors occurring in experimental mouse and human melanoma tumours as well as in human melanoma biopsies. For this reason, solid tumours were grown on experimental animals by inoculation of murine B16-F1 an d human D10 and HBL melanoma cells. After excision and cryosectioning of the tumours, frozen tissue sections were incubated with [(I-125)Tyr (2)]-alpha-MSH or [(I-I25)Tyr(2),Nle(4),D-Phe(7)]-alpha-MSH and specif ic alpha-MSH binding sites were visualized by subsequent autoradiograp hy. The presence of increasing concentra-tions of unlabelled alpha-MSH during incubation with tracer led to a dose-dependent displacement of the radioligand. Quantitative analysis of the autoradiograms produced dissociation constants which were comparable with those obtained with cell binding assays: K-D = 1.87 and 1.31 nmol/l for B16 tumours and c ells, respectively; 0.32 and 0.33 nmol/l for D10, and 2.24 and 1.36 nm ol/l for HBL tumours and cells, respectively. This indicates similar b inding properties of alpha-MSH radioligands to both cultured melanoma cells and tissue sections of melanoma tumours from experimental animal s. Similar binding characteristics were also observed with human melan oma tissue sections originating from biopsies of melanoma patients.